Nihon Kohden Corporation (6849) AI Stock Analysis

• Market Cap: ¥288.81B
• Dividend Yield: 1.79%
• Average Volume (3M): 547.20K
• Price to Earnings (P/E): 16.7
• Beta (1Y): 0.78
• Revenue Growth: 2.79%
• EPS Growth: 7.64%
• Country: JP
• Employees: 5,891
• Sector: Healthcare
• Sector Strength: 69
• Industry: Medical - Devices
• EPS (TTM): 103.48
• Shares Outstanding: 170,961,960
• 10 Day Avg. Volume: 398,090
• 30 Day Avg. Volume: 547,196
• PEG Ratio: 2.19
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• Price to Cash Flow (P/CF): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,680.00
• Price Target Upside: 54.91% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

Nihon Kohden Corporation presents a strong financial foundation with robust revenue growth and profitability, contributing positively to the stock's score. However, technical analysis indicates short-term bearish momentum, which could pose challenges to immediate stock price appreciation. Valuation metrics suggest the stock is fairly priced with a modest dividend yield, making it an attractive option for long-term investors. Overall, the company's solid financials and reasonable valuation offset the current technical weaknesses, resulting in a balanced stock score.

Nihon Kohden Corporation Business Overview & Revenue Model

Company Description

Nihon Kohden Corporation is a leading Japanese medical electronics manufacturer specializing in the development, production, and distribution of medical devices and equipment. The company operates primarily in the healthcare sector and offers a wide range of products, including patient monitoring systems, diagnostic equipment, and therapeutic instruments. Nihon Kohden is renowned for its innovative technologies in electroencephalographs (EEG), electrocardiographs (ECG), and other clinical information systems that enhance patient care and medical research.

How the Company Makes Money

Nihon Kohden Corporation generates revenue through the sale of its medical devices and equipment to hospitals, clinics, and other healthcare facilities worldwide. The company's key revenue streams include patient monitoring systems, which are critical for continuous monitoring of patients' vital signs, and diagnostic and therapeutic instruments such as EEG and ECG machines. Additionally, Nihon Kohden offers service contracts and maintenance agreements, ensuring long-term customer relationships and recurring revenue. The company also collaborates with healthcare institutions and research organizations, contributing to steady demand for its advanced medical technologies. Significant factors contributing to its earnings include its strong brand reputation, continuous investment in research and development for innovative products, and a global distribution network that expands its reach into international markets.

Nihon Kohden Corporation Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
221.99B	206.60B	205.13B	199.73B	185.01B
	Gross Profit
111.35B	105.93B	109.09B	102.23B	89.33B
	EBIT
19.59B	21.12B	30.99B	27.09B	15.50B
	EBITDA
23.45B	24.91B	34.48B	31.64B	19.25B
	Net Income Common Stockholders
17.03B	17.11B	23.43B	18.24B	9.85B
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
50.43B	44.46B	60.92B	44.61B	35.97B
	Total Assets
233.23B	216.73B	210.20B	193.03B	167.79B
	Total Debt
654.00M	441.00M	359.00M	404.00M	401.00M
	Net Debt
-35.48B	-33.02B	-28.57B	-30.20B	-20.57B
	Total Liabilities
52.15B	49.13B	53.82B	54.05B	46.01B
	Stockholders Equity
181.08B	167.60B	156.38B	138.98B	121.77B
Cash Flow		Free Cash Flow
10.82B	-10.77B	22.77B	10.56B	5.63B
	Operating Cash Flow
15.61B	-2.51B	25.70B	13.95B	9.22B
	Investing Cash Flow
-5.21B	-7.65B	-4.30B	-2.95B	-4.61B
	Financing Cash Flow
-6.97B	-7.49B	-7.30B	-3.01B	-3.05B

Nihon Kohden Corporation Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1730.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6849, the sentiment is Negative. The current price of 1730 is below the 20-day moving average (MA) of 1805.30, below the 50-day MA of 2010.75, and below the 200-day MA of 2085.02, indicating a bearish trend. The MACD of -82.48 indicates Negative momentum. The RSI at 36.69 is Neutral, neither overbought nor oversold. The STOCH value of 38.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:6849.

Nihon Kohden Corporation Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4543	78 Outperform	$3.96T	31.74	9.39%	0.86%	14.23%	26.82%
4540	76 Outperform	$326.38B	12.01	9.38%	3.03%	15.46%	62.01%
7701	70 Outperform	$1.04T	19.27	11.29%	1.60%	4.36%	-1.76%
7733	69 Neutral	$2.01T	24.47	12.71%	1.03%	7.60%	-66.30%
6849	65 Neutral	¥288.81B	16.72		1.79%	2.79%	7.64%
7702	61 Neutral	¥11.12B	93.88		3.74%	7.76%	-41.79%
Sector *	51 Neutral	$5.31B	3.39	-40.42%	2.90%	18.11%	2.25%

Nihon Kohden Corporation Corporate Events

Nihon Kohden Announces Leadership Changes

Nihon Kohden Corporation announced a significant change in its leadership, with the retirement of Representative Director Takashi Tamura due to health reasons, effective June 26, 2025. The company also introduced new director candidates, including Kazuhiro Kato and Mamoru Morita, as part of its strategic leadership restructuring, which could impact its corporate governance and strategic direction.

Nihon Kohden Completes Share Buyback Program

Nihon Kohden Corporation announced the completion of its share buyback program, acquiring a total of 493,200 common shares for approximately 1.05 billion yen through market purchases on the Tokyo Stock Exchange. This acquisition finalizes the company’s plan, initially resolved by the Board of Directors in May 2024, to buy back up to 6 million shares, aiming to enhance shareholder value and optimize capital structure.

Nihon Kohden Advances Share Buyback Program

Nihon Kohden Corporation announced the acquisition of 562,200 of its own shares, amounting to 1,260,127,300 yen, as part of a broader share buyback program approved by its Board of Directors. This strategic move, conducted through market purchases on the Tokyo Stock Exchange, is part of a larger plan to acquire up to 6,000,000 shares, reflecting the company’s efforts to optimize capital structure and enhance shareholder value.

Nihon Kohden Reports Significant Forex Gains in Q3 FY2024

Nihon Kohden Corporation reported recording non-operating income from foreign exchange gains in the third quarter of the fiscal year ending March 31, 2025. The gains amounted to ¥5,380 million, offsetting previous foreign exchange losses of ¥3,327 million in the first half of FY2024, resulting in net gains of ¥2,052 million for the nine-month period. This financial development is attributed to the revaluation of foreign currency-denominated assets due to exchange rate fluctuations, potentially impacting the company’s business performance and financial position positively.

Nihon Kohden Reports FY2024 Q3 Financial Decline Amid Strategic Adjustments

Nihon Kohden Corporation reported a decline in consolidated financial results for the third quarter of FY2024, with net sales and operating income showing significant decreases compared to the same period last year. The company also implemented a stock split in July 2024, affecting dividend calculations and share figures, which reflects its strategic adjustments amidst challenging market conditions.

Nihon Kohden Updates on Share Buyback Status

Nihon Kohden Corporation announced the ongoing status of its share buyback program, which was resolved by its Board of Directors in May 2024. As of January 31, 2025, the company has acquired 3,702,000 of its own shares, amounting to a total acquisition cost of 7,687,186,000 yen, with the acquisitions conducted via market purchases on the Tokyo Stock Exchange. This move is part of an ongoing acquisition plan to purchase up to 6,000,000 shares by March 31, 2025, reflecting the company’s strategic financial management and potential efforts to enhance shareholder value.